ARCHIVES

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

This article is from The Cancer Letter archive.

Vol. 39 No. 44 | November 22, 2013

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

June 11, 2004

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Panel to Hear Innovation Reports

August 26, 1988

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992